Announcements Trials
Browse Landscape

Phase

Phase 4 2Phase NA 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 16OTHER_GOV 2NIH 2FED 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Colorectal Neoplasms 4Rectal Neoplasms 2Neoplasms by Site 2Neoplasms 2Colonic Neoplasms 2Urogenital Neoplasms 1Skin Neoplasms 1Skin Diseases 1Renal Insufficiency, Chronic 1Renal Artery Obstruction 1Pulmonary Embolism 1Prostatic Neoplasms, Castration-Resistant 1Prostatic Neoplasms 1Prostatic Diseases 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pain, Postoperative 1Opioid-Related Disorders 1Neoplasms, Squamous Cell 1Neoplasms, Basal Cell 1Male Urogenital Diseases 1Lung Neoplasms 1Herpes Zoster 1Genital Neoplasms, Male 1Genital Diseases, Male 1Colonic Polyps 1Colon Cancer Screening 1Chronic Pain 1Carcinoma, Squamous Cell 1Carcinoma, Basal Cell 1Carcinoma 1

Interventions

Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × FED × Rectal Neoplasms × Clear all
NCT00134589 2009-08-04

CHOICE: Communicating Health Options Through Information and Cancer Education

Centers for Disease Control and Prevention

Phase 4 Completed
450 enrolled
Gastrointestinal

Colonic Polyps, Rectal Neoplasms, Colorectal Neoplasms

NCT00216424 2007-11-12

Capecitabine (Xeloda) and Radiation for Patients With Rectosigmoid Carcinoma

James A. Haley Veterans Administration Hospital

Phase 4 Terminated
40 enrolled
Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡